Adicet Bio Gains FDA Clearance for ADI-212 IND in mCRPC
REDWOOD CITY, Calif. – August 27, 2026 Adicet Bio, Inc. announced that the U.S. Food and Drug Administration (FDA)...
CAR T Cell Therapy
Advertisement
Fate Therapeutics Advances FT819 in Lupus Nephritis
San Diego, California — August 14, 2026 Fate Therapeutics, Inc. has initiated the potentially registrational RECLAIM-LN Phase 2 clinical...
Allogene Therapeutics Receives FDA RMAT Status for Cema-Cel
SOUTH SAN FRANCISCO, Calif., July 29, 2026 Allogene Therapeutics announced that the U.S. Food and Drug Administration (FDA) has...
Lyell Immunopharma Showcases Updated Ronde-Cel Data at EHA 2026
SOUTH SAN FRANCISCO, Calif., June 12, 2026 Lyell Immunopharma, Inc. announced updated safety and translational data for rondecabtagene autoleucel...
CARsgen Reports 4.5-Year Follow-Up Data for Satri-cel in Advanced Gastric Cancer at ASCO 2026
SHANGHAI, China, June 1, 2026 CARsgen Therapeutics presented promising long-term follow-up data from its investigational Claudin18.2-targeted CAR T-cell therapy,...
Advertisements
Sana Biotechnology Advances In Vivo CAR T Platform
SEATTLE, May 12, 2026 Sana Biotechnology announced new preclinical findings at the 2026 American Society of Gene & Cell...
CU Anschutz Secures FDA IND for CAR T-Cell Therapy
AURORA, Colo., April 2, 2026 The University of Colorado Anschutz Medical Campus Gates Institute announced it has received U.S....
Advertisement
